Cocrystal Pharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Cocrystal Pharma, Inc. (COCP) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents9.8626.3537.1458.7133.017.47
Cash & Short-Term Investments9.8626.3537.1458.7133.017.47
Accounts Receivable1.220.890.720.000.560.64
Inventory0.000.000.000.000.000.00
Other Current Assets0.431.772.240.570.400.00
Total Current Assets11.5829.0940.1859.3234.028.28
Non-Current Assets
Property, Plant & Equipment (Net)1.852.120.620.931.091.11
Goodwill0.000.000.0019.0919.090.00
Other Non-Current Assets0.030.050.050.050.050.00
Total Non-Current Assets1.882.170.6620.0720.2320.25
Total Assets13.4631.2640.8479.3954.2428.53
Current Liabilities
Accounts Payable1.543.020.611.300.662.00
Short-Term Debt0.300.000.000.000.000.00
Accrued Liabilities0.471.690.230.620.420.00
Other Current Liabilities0.590.110.130.100.060.00
Total Current Liabilities2.433.261.221.551.362.29
Non-Current Liabilities
Long-Term Debt1.511.610.060.300.380.54
Other Non-Current Liabilities0.000.000.000.000.000.06
Total Non-Current Liabilities1.511.610.060.300.380.54
Total Liabilities3.934.881.271.841.742.82
Stockholders' Equity
Common Stock0.010.010.010.010.070.00
Retained Earnings-333.42-315.91-297.93-259.09-244.91-235.26
Additional Paid-in Capital342.93342.29337.49336.63297.34260.93
Shares Outstanding10.1710.178.148.120.000.00
Total Stockholders' Equity9.5226.3839.5777.5552.5125.71
Total Liabilities & Equity13.4631.2640.8479.3954.2428.53